Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
And yet you're still a loyal shareholder. 👺
Unlike NWBO, they have no pivotal results yet... nothing has been submitted, but the FDA is waiting on the BPs to submit. SMH
This is why it's advantageous for NWBO to pursue UK first.
'We're open for business': FDA's Peter Marks says agency ready to review novel cancer vaccines despite unknowns
As new cancer vaccines—led by Moderna and Merck’s mRNA-4157—near pivotal trial readouts, the FDA’s vaccines czar Peter Marks, M.D., Ph.D., said the agency is ready to review the shots despite AI-related unknowns.
“We are ready to review—we’re open for business,” Marks, director of the FDA’s Center for Biologics Evaluation and Research, said of cancer vaccines at the 2024 World Vaccine Congress (WVC).
“We have therapeutic cancer vaccines coming in; I think we would review them very much like we could review potentially a CAR-T cell or other therapeutic products,” Marks said.
We can always count on "associates" to come to the defense. Must protect the tribe, right?
Yeah, it certainly helps to be privy to the collusive HF handlers' "script", doesn't it? No doubt, it's much easier to make a profit knowing that another planned short attack was in the works with the CTAD AD readout and to sell ahead of it... as opposed to having to rely on one's own anticipations of their actions, which is certainly not as accurate or guaranteed. Makes it that much easier to be playing with the house's (i.e. retail's) money, as one claims.
These postings by Anavex may very well be indicative and suggestive to the scope of the content in the forthcoming peer-reviewed journal article. AD. PDD, and perhaps more?
This sort of suggests, as I've been speculating, that the PDD data will likely be included with the AD data in a comprehensive peer-reviewed article on the efficacy and safety of blarcamesine. It would make complete sense. We'll soon see...
Here it is; just for you... 🖕
I sell every manipulated SP pop that your handlers orchestrate... because they always walk it back down, where one can reload. Again, tell your handlers 'thanks' for me. $$$
Damn right... reloaded all 100k shares by EOD. Tell your handlers 'thanks' for me! $$$
Yep, the collusive manipulators have to cover their collusive short positions eventually...
I'll gladly take a $10k profit on a quick 100k-sh sale and a reload .10 lower... while holding a large core position.
Bought back half (50k) and will buy the rest back EOD. So, go pound sand, FUDster!
More accurately... the capitulation post 20% gain is nearing exhaustion and about to charge higher, through the .65 resistance. I'll be reloading yesterday's sold shares soon ~.58.
Spot on! There's plenty of hired-hands to go around, with AF being their king FUD mouthpiece. Just look at how many they hire to work this board...
BIOChecker4 (voted biggest 👺)
Investor2014
DoTheRightThing
BakedLangostino
windsurfar51
kund
BDR10
Reyeton
jav0033
poguemahone
sumbuysumsell
go avxl
avxllent
mrplmer
crescentmotor
attilathehunt
FooBarAndGrill
Jonjones325
Tobiasjosias
LarryMexico28
mr.sinister
CashMoney75
loyalinvestor1212
SquealingSquid
ExtremelyBullishZig
CosmicOracle42
DRexpact
JKS3
Kb1123
Rikker19
PsuLion
growingpain
Inquirig
Spudskie
Tootalljones
rayovacAAA
Anshu2
OFP
frrol
Doc328
LakeshoreLeo1935 (voted biggest 🤡)
So, you don't think that the PDD data will be included with the AD data in the peer-reviewed journal? Since the two are closely related, it would seem a good opportunity to provide a comprehensive analysis of blarcamesine's efficacy & safety with the implication that it'll be effective therapy in addressing multiple degenerative CNS indications.
I think there's a distinct possibility.
In the past months, institutions appear to be buying, not selling... regardless of the fund type. They know the collusive HF shenanigans being played and perhaps are part and party to it. I suspect they'll be buying more. If they're buying more then we should do the same... and soon... before the peer-reviewed journal is published.
The partnerships could be in the form of franchises, outside of the UK.
You misspelled cabal again. Not one person here truly believes this sell down is "market" driven... nope, not one. Everyone knows it's the work of collusive manipulation by a handful of HFs (the FUDsters' employers) to attack a biotech that is about to submit an MAA and have its AD (+PDD?) data published in a peer-reviewed journal. Their mission is to drive retail investors out so that they and their institutional buddies can load up on cheap shares. It's an all too familiar tactic that's been done to many biotechs in the past. FUDsters work day, night and weekends for their handlers to provide a FUD-based smokescreen cover.
It seems he fully expects DCVax-L to be approved soon...
Mr. Sarma commented, "I am honored to be asked to join the Board of NWBio at this exciting and pivotal time in the Company's history. This is one of the most significant opportunities I have encountered in my career to help make a positive difference to so many people."
The only selling/shorting is by the same collusive manipulation machine (small trades) as always... their purpose is to walk it down till news. It's one big scare tactic.
Your own advice: be skeptical of posters on this MB. Yours is a prime example. 👺
And yet you claim to be a shareholder. LOL
We fully expected an organized short attack from $10 down, regardless of how excellent the Rett trial outcome was... it was going to happen; it always does. The only question was how big of lies were the FUDsters going to tell as cover. Investor tipped us off in Nov when he stated that he was expecting "cherry picked" data with the Excellence trial. We appreciated the tip, Investor. It confirmed for us to get out at $10. Now we sit with double our share count.
You want to blame the trial results for the SP decline, but in reality it's always the result of an organized short attack. But you know this.
Never take anything Missling or anything anyone else here says at face value.
I fully expect them to be seeking FDA guidance for NDA submission for Rett in total, as the Excellence results clearly demonstrated efficacy and safety, even if the results weren't technically stat. sig., due to the extraordinarily large placebo response, which can easily be explained and likely accepted by regulators. Regulators will review the entirety of data when making their decision, including the years of extension data demonstrating QoL improvements and substantial reduction in seizure frequency.
In the meantime we wait for the peer-reviewed journal article and MAA submission for AD.
Ask your handlers...
Why does it go down everyday?
The only motives investors question here are those by non-shareholders and supposed "shareholders" who post blatant lies every single day about the science, company and/or CEO. It's not a "public service" they provide. Nope... they are paid to be here; they have a job to do. Their employers (directly or indirectly) are none other than the HFs who are being sued; those who manipulate and suppress the SP. It's a nefariously collusive business and their motives, through these paid FUDsters, are to try to convince real shareholders to sell. Little do they know how futile their efforts are. Like trying to convince people that the earth is flat or that the sun won't rise in the morning. Yes, total nonsense... but that's what they're paid to do. Everyone here knows to just ignore them.
You're an idiot. 👺🐀
I'm in the camp that believes they plan to franchise the technology outside of the UK. That will facilitate a ramp up of production and revenues in multiple countries beyond their UK commercialization... and a proper valuation for a future buyout.
However, an interested BP suitor would likely not want to deal with a franchise arrangement and might very well preclude those plans with a legitimate BO offer.
I agree with your supposition, as PDD is certainly related to AD and will add further evidence of efficacy and safety. It is why I believe we'll also see the PDD data included in the peer-reviewed journal article. Not only is it relative, but why wouldn't a company include it into one larger encompassing article rather than push two separate articles? Perhaps it's one reason for the time it's taking to get published.
KG pays off others to get his way... why not CNBC to change from RTQ on securities he's manipulating.
Does anyone know of another site to get RTQ on NWBO for free?
LOL. A supposed "shareholder" who can't stand that real shareholders are trading the manipulation and reloading/adding under $5. Your true 👺 colors are showing.
Care to guess how many 10s of thousands of those shares were purchased by us, sub $5?
You seem quite happy about the downward manipulation of the SP. That's rather odd for a supposed "shareholder". I guess you must be adding too. LOL
Most everyone knows the answer to your questions... think HF cabal (Citadel, Susquehanna, Virtu, Canaccord, G1, Instinet and Score)
No, you're not! You most certainly are paid to post FUD here every day!
I'd prefer discovery. Want to see Fraudstein exposed for his association with the HF "mob". After all, Citadel referenced his (paid for) lying hit pieces that supposedly prompted all the shorting. Would love to see Fraudstein take the stand... along with his associate criminal traders.
As expected, the manipulators are providing another opportunity to reload previously sold shares... ~50c lower. Thanks!
Expect these manipulated gyrations for some time, as they have millions of collusive short positions needing to cover.
You weren't exactly honest with ChatGPT... you didn't reveal that you were just a "google neurologist"... not the same as a real neurologist. A real neurologist doesn't have time to work a MB daily.
All I see is just another lame paid FUDster out to make a buck. What a pathetic existence!
I guess it beats living on the street... but not by much.
You didn't answer my question... which HF handler do you work for, Citadel, Susquehanna or another criminal org?